Carisma Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Carisma Therapeutics has a total shareholder equity of $360.0K and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $59.3M and $59.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$41.91m |
Equity | US$360.00k |
Total liabilities | US$58.98m |
Total assets | US$59.34m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: W2J's short term assets ($50.7M) exceed its short term liabilities ($15.6M).
Long Term Liabilities: W2J's short term assets ($50.7M) exceed its long term liabilities ($43.4M).
Debt to Equity History and Analysis
Debt Level: W2J is debt free.
Reducing Debt: W2J had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: W2J has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: W2J has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 54.6% each year.